Coherus Oncology, Inc. Common Stock
CHRS
CHRS
116 hedge funds and large institutions have $50.1M invested in Coherus Oncology, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-6
Holders Change %
-4.92%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
40
Reduced
32
Closed
17
Calls
$173K
Puts
$67K
Net Calls
+$106K
Net Calls Change
-$7.1M
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.49M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.17M |
| 3 |
Citigroup
New York
|
+$437K |
| 4 |
Renaissance Technologies
New York
|
+$412K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$299K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.29M |
| 2 |
Morgan Stanley
New York
|
-$1.54M |
| 3 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$782K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$441K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$274K |
